RPRX logo

Royalty Pharma (RPRX) Selling, General & Administrative Expenses

Annual SGA

$249.75 M
+$22.45 M+9.87%

December 31, 2023


Summary


Performance

RPRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXexpensesmetrics:

Quarterly SGA

$56.72 M
+$2.01 M+3.68%

September 30, 2024


Summary


Performance

RPRX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXexpensesmetrics:

TTM SGA

$10.09 B
+$630.00 M+6.66%

September 30, 2024


Summary


Performance

RPRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

RPRX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.9%-1.6%+4450.2%
3 y3 years+37.4%-1.6%+4450.2%
5 y5 years+303.4%+121.5%+9652.6%

RPRX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+36.6%-33.8%+22.9%at high+17.7%
5 y5-yearat high+141.4%-33.8%+146.0%at high+257.1%
alltimeall timeat high+303.4%-33.8%+146.0%at high+257.1%

Royalty Pharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$56.72 M(+3.7%)
$228.26 M(-0.2%)
Jun 2024
-
$54.71 M(-5.1%)
$228.78 M(+3.2%)
Mar 2024
-
$57.65 M(-2.6%)
$221.71 M(-11.2%)
Dec 2023
$249.75 M(+9.9%)
$59.19 M(+3.4%)
$249.75 M(-5.3%)
Sep 2023
-
$57.23 M(+20.2%)
$263.79 M(+2.5%)
Jun 2023
-
$47.63 M(-44.4%)
$257.25 M(-1.6%)
Mar 2023
-
$85.69 M(+17.0%)
$261.46 M(+15.0%)
Dec 2022
$227.30 M(+24.3%)
$73.23 M(+44.5%)
$227.30 M(+13.5%)
Sep 2022
-
$50.69 M(-2.2%)
$200.24 M(+1.1%)
Jun 2022
-
$51.84 M(+0.6%)
$198.13 M(+3.6%)
Mar 2022
-
$51.54 M(+11.7%)
$191.21 M(+4.6%)
Dec 2021
$182.83 M
$46.16 M(-5.0%)
$182.83 M(-2.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
$48.59 M(+8.2%)
$186.78 M(-1.1%)
Jun 2021
-
$44.92 M(+4.1%)
$188.93 M(+1.1%)
Mar 2021
-
$43.16 M(-13.9%)
$186.81 M(+2.8%)
Dec 2020
$181.72 M(+75.7%)
$50.12 M(-1.2%)
$181.72 M(+17.5%)
Sep 2020
-
$50.73 M(+18.5%)
$154.66 M(+19.4%)
Jun 2020
-
$42.80 M(+12.4%)
$129.53 M(+10.6%)
Mar 2020
-
$38.06 M(+65.1%)
$117.08 M(+13.2%)
Dec 2019
$103.44 M(+67.1%)
$23.06 M(-9.9%)
$103.44 M(+28.7%)
Sep 2019
-
$25.60 M(-15.6%)
$80.38 M(+46.7%)
Jun 2019
-
$30.35 M(+24.2%)
$54.77 M(+124.2%)
Mar 2019
-
$24.43 M
$24.43 M
Dec 2018
$61.91 M(-41.8%)
-
-
Dec 2017
$106.44 M
-
-

FAQ

  • What is Royalty Pharma annual SGA?
  • What is the all time high annual SGA for Royalty Pharma?
  • What is Royalty Pharma annual SGA year-on-year change?
  • What is Royalty Pharma quarterly SGA?
  • What is the all time high quarterly SGA for Royalty Pharma?
  • What is Royalty Pharma quarterly SGA year-on-year change?
  • What is Royalty Pharma TTM SGA?
  • What is the all time high TTM SGA for Royalty Pharma?
  • What is Royalty Pharma TTM SGA year-on-year change?

What is Royalty Pharma annual SGA?

The current annual SGA of RPRX is $249.75 M

What is the all time high annual SGA for Royalty Pharma?

Royalty Pharma all-time high annual SGA is $249.75 M

What is Royalty Pharma annual SGA year-on-year change?

Over the past year, RPRX annual SGA has changed by +$22.45 M (+9.87%)

What is Royalty Pharma quarterly SGA?

The current quarterly SGA of RPRX is $56.72 M

What is the all time high quarterly SGA for Royalty Pharma?

Royalty Pharma all-time high quarterly SGA is $85.69 M

What is Royalty Pharma quarterly SGA year-on-year change?

Over the past year, RPRX quarterly SGA has changed by -$932.00 K (-1.62%)

What is Royalty Pharma TTM SGA?

The current TTM SGA of RPRX is $10.09 B

What is the all time high TTM SGA for Royalty Pharma?

Royalty Pharma all-time high TTM SGA is $10.09 B

What is Royalty Pharma TTM SGA year-on-year change?

Over the past year, RPRX TTM SGA has changed by +$9.87 B (+4450.18%)